Low dose cytokines reduce oxidative stress in primary lesional fibroblasts obtained from psoriatic patients

J Dermatol Sci. 2016 Sep;83(3):242-4. doi: 10.1016/j.jdermsci.2016.06.002. Epub 2016 Jun 1.

Authors

Victoria Barygina¹, Matteo Becatti², Torello Lotti³, Niccolò Taddei², Claudia Fiorillo²

Affiliations

¹ Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni, 50, 50134 Florence, Italy. Electronic address: v.barygina@gmail.com.
² Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni, 50, 50134 Florence, Italy.
³ Dermatology and Venereology Division, Guglielmo Marconi University, Via Plinio, 44, 00193 Roma, Italy.

PMID: 27317477
DOI: 10.1016/j.jdermsci.2016.06.002

No abstract available

Publication types

Letter

MeSH terms

Antioxidants / pharmacology*
Case-Control Studies
Cells, Cultured
Cytokines / pharmacology*
Fibroblasts / drug effects*
Fibroblasts / metabolism
Humans
NADPH Oxidases / metabolism
Oxidative Stress / drug effects*
Primary Cell Culture
Psoriasis / metabolism*
Reactive Oxygen Species / metabolism
Skin / drug effects*
Skin / metabolism
Time Factors

Substances

Antioxidants
Cytokines
Reactive Oxygen Species
NADPH Oxidases